14 studies found for:    HCV | Open Studies | Interventional Studies | United States, Florida | Adult | Phase 2, 3, 4
Show Display Options
Rank Status Study
1 Recruiting Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: SOF/GS-5816;   Drug: Placebo to match SOF/GS-5816
Age Groups: Adult / Senior
2 Recruiting Comparison of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: SOF/GS-5816;   Drug: SOF;   Drug: RBV
Age Groups: Adult / Senior
3 Recruiting Comparison of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: SOF/GS-5816;   Drug: SOF;   Drug: RBV
Age Groups: Adult / Senior
4 Recruiting A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Condition: Chronic Hepatitis C Virus (HCV) Infection Genotype 1
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
Age Groups: Adult / Senior
5 Recruiting Sofosbuvir/GS-5816 Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis
Condition: Hepatitis C Virus Infection
Interventions: Drug: SOF/GS-5816;   Drug: RBV
Age Groups: Adult / Senior
6 Recruiting An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant
Condition: Hepatitits C
Interventions: Drug: Simeprevir;   Drug: Sofosbuvir;   Drug: Ribavirin
Age Groups: Adult / Senior
7 Recruiting Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Conditions: Hepatitis C Infection;   Viruses;   Hepatocellular Carcinoma;   Hepatitis, Viral, Human;   Liver Cirrhosis
Intervention: Biological: Civacir® 10%
Age Groups: Adult / Senior
8 Recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 (HIV-1) Coinfection
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
Age Groups: Adult / Senior
9 Recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
Conditions: Chronic Hepatitis C Infection;   Compensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir
Age Groups: Adult / Senior
10 Recruiting Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis
Condition: Hepatitis C Virus Infection
Interventions: Drug: Sofosbuvir;   Drug: RBV
Age Groups: Adult / Senior
11 Recruiting Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in Treatment-Naïve HCV Genotype 1-Infected Adults With Chronic Kidney Disease
Conditions: Chronic Hepatitis C;   Hepatitis C Virus;   Compensated Cirrhosis;   Severe Renal Impairment;   End-stage Renal Disease
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir;   Drug: Ribavirin
Age Groups: Adult / Senior
12 Recruiting A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
Conditions: Liver Fibrosis;   Hepatic Fibrosis
Intervention: Drug: IDN-6556
Age Groups: Adult / Senior
13 Recruiting Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected Patients
Condition: Hepatitis C
Interventions: Drug: BZF961;   Drug: Ritonavir;   Drug: Placebo
Age Groups: Child / Adult / Senior
14 Recruiting Sofosbuvir Plus Ribavirin in Subjects With HCV Infection and Renal Insufficiency
Condition: HCV Infection
Interventions: Drug: Sofosbuvir;   Drug: RBV
Age Groups: Adult / Senior

Indicates status has not been verified in more than two years